Miracll ChemicalsLtd Past Earnings Performance
Past criteria checks 1/6
Miracll ChemicalsLtd has been growing earnings at an average annual rate of 0.6%, while the Chemicals industry saw earnings growing at 4.9% annually. Revenues have been growing at an average rate of 19.5% per year. Miracll ChemicalsLtd's return on equity is 4.4%, and it has net margins of 4.3%.
Key information
0.6%
Earnings growth rate
-9.0%
EPS growth rate
Chemicals Industry Growth | 12.1% |
Revenue growth rate | 19.5% |
Return on equity | 4.4% |
Net Margin | 4.3% |
Last Earnings Update | 30 Sep 2024 |
Recent past performance updates
Recent updates
The Returns On Capital At Miracll ChemicalsLtd (SZSE:300848) Don't Inspire Confidence
Dec 12Miracll ChemicalsLtd (SZSE:300848) Takes On Some Risk With Its Use Of Debt
Nov 16Miracll Chemicals Co.,Ltd (SZSE:300848) Stocks Shoot Up 41% But Its P/S Still Looks Reasonable
Oct 09Here's Why Miracll ChemicalsLtd (SZSE:300848) Has A Meaningful Debt Burden
Jul 13Miracll ChemicalsLtd (SZSE:300848) Has Announced A Dividend Of CN¥0.10
May 26Miracll Chemicals Co.,Ltd's (SZSE:300848) 26% Jump Shows Its Popularity With Investors
May 22Miracll ChemicalsLtd's (SZSE:300848) Anemic Earnings Might Be Worse Than You Think
Apr 29Market Participants Recognise Miracll Chemicals Co.,Ltd's (SZSE:300848) Earnings Pushing Shares 29% Higher
Mar 29Revenue & Expenses Breakdown
How Miracll ChemicalsLtd makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
---|---|---|---|---|
30 Sep 24 | 1,591 | 69 | 63 | 83 |
30 Jun 24 | 1,557 | 68 | 61 | 81 |
31 Mar 24 | 1,543 | 77 | 60 | 77 |
31 Dec 23 | 1,475 | 88 | 58 | 73 |
30 Sep 23 | 1,426 | 100 | 52 | 72 |
30 Jun 23 | 1,401 | 107 | 49 | 67 |
31 Mar 23 | 1,402 | 112 | 46 | 69 |
01 Jan 23 | 1,475 | 111 | 44 | 70 |
30 Sep 22 | 1,561 | 124 | 44 | 72 |
30 Jun 22 | 1,565 | 129 | 43 | 71 |
31 Mar 22 | 1,416 | 119 | 42 | 62 |
01 Jan 22 | 1,298 | 119 | 40 | 56 |
30 Sep 21 | 1,152 | 119 | 36 | 49 |
30 Jun 21 | 1,005 | 111 | 35 | 44 |
31 Mar 21 | 915 | 115 | 31 | 40 |
31 Dec 20 | 757 | 102 | 26 | 32 |
30 Sep 20 | 985 | 123 | 47 | 36 |
30 Jun 20 | 650 | 87 | 33 | 24 |
31 Mar 20 | 625 | 77 | 37 | 23 |
31 Dec 19 | 649 | 83 | 39 | 24 |
30 Sep 19 | 320 | 33 | 19 | 12 |
30 Jun 19 | 573 | 62 | 33 | 21 |
31 Mar 19 | 582 | 59 | 32 | 21 |
31 Dec 18 | 592 | 55 | 31 | 21 |
30 Sep 18 | 589 | 52 | 31 | 21 |
30 Jun 18 | 586 | 49 | 31 | 20 |
31 Mar 18 | 556 | 47 | 28 | 19 |
31 Dec 17 | 526 | 44 | 26 | 19 |
30 Sep 17 | 480 | 40 | 27 | 14 |
30 Jun 17 | 433 | 36 | 28 | 9 |
31 Mar 17 | 384 | 32 | 31 | 5 |
31 Dec 16 | 335 | 27 | 34 | 0 |
30 Sep 16 | 293 | 26 | 31 | 0 |
30 Jun 16 | 252 | 25 | 28 | 0 |
31 Mar 16 | 236 | 21 | 25 | 0 |
31 Dec 15 | 220 | 17 | 22 | 0 |
31 Dec 14 | 162 | 3 | 16 | 0 |
Quality Earnings: 300848 has a high level of non-cash earnings.
Growing Profit Margin: 300848's current net profit margins (4.3%) are lower than last year (7%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: 300848's earnings have grown by 0.6% per year over the past 5 years.
Accelerating Growth: 300848's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.
Earnings vs Industry: 300848 had negative earnings growth (-30.8%) over the past year, making it difficult to compare to the Chemicals industry average (-4.7%).
Return on Equity
High ROE: 300848's Return on Equity (4.4%) is considered low.
Return on Assets
Return on Capital Employed
Discover strong past performing companies
Company Analysis and Financial Data Status
Data | Last Updated (UTC time) |
---|---|
Company Analysis | 2024/12/26 05:00 |
End of Day Share Price | 2024/12/26 00:00 |
Earnings | 2024/09/30 |
Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
Package | Data | Timeframe | Example US Source * |
---|---|---|---|
Company Financials | 10 years |
| |
Analyst Consensus Estimates | +3 years |
|
|
Market Prices | 30 years |
| |
Ownership | 10 years |
| |
Management | 10 years |
| |
Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Miracll Chemicals Co.,Ltd is covered by 2 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
Analyst | Institution |
---|---|
Zhe Wang | Citic Securities Co., Ltd. |
Nan Xie | Zhongtai Securities Co. Ltd. |